Welcome - development continues on our new site, please check back often!

COARE Biotechnology, Inc. is a drug development company that seeks to advance the current treatment modality of patients with aggressive cancers by coordinately targeting aspects of both the primary tumor and the biological processes that effect metastatic initiation and progression. We are currently developing several novel therapeutic technologies, including immunotherapy and nanomedicine, aimed at targeting the master regulatory processes that have been hijacked and are used to support the cancer microenvironment.